비교리스트

 카트 문의
시장보고서
상품코드
1655473

세계의 피브린 실란트 시장

Fibrin Sealants
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 92 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 피브린 실란트 시장은 2030년까지 16억 달러에 도달

2024년에 11억 달러로 추정되는 세계의 피브린 실란트 시장은 2024-2030년에 CAGR 6.1%로 성장하며, 2030년에는 16억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 피브린 실란트액은 CAGR 6.4%를 기록하며, 분석 기간 종료시에는 12억 달러에 달할 것으로 예측됩니다. 피브린 실란트 패치 부문의 성장률은 분석 기간 중 CAGR 5.4%로 추정됩니다.

미국 시장은 2억 9,310만 달러로 추정, 중국은 CAGR 9.1%로 성장 예측

미국의 피브린 실란트 시장은 2024년에 2억 9,310만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 9.1%로 견인하며 2030년까지 3억 6,410만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.3%와 5.9%로 예측됩니다. 유럽에서는 독일이 CAGR 3.7%로 성장할 것으로 예측됩니다.

세계의 피브린 실란트 시장 - 주요 동향과 촉진요인 정리

피브린 실란트는 무엇이며, 왜 의료 용도에 필수적인가?

피브린 실란트는 상처 치유와 조직 회복을 촉진하기 위해 다양한 의료용으로 사용되는 생물학적 접착제의 일종입니다. 피브리노겐과 트롬빈으로 구성된 이 실란트는 혈액 응고 과정의 마지막 단계를 모방하여 상처를 효과적으로 밀봉하고 지혈을 촉진하는 피브린 덩어리의 형성을 촉진합니다. 피브린 실란트는 일반 외과, 정형외과, 신경외과, 심혈관외과 등 다양한 외과수술에 사용됩니다. 조직 표면에 접착하고 출혈을 억제하며 치유를 촉진하는 능력은 외과 의사와 의료 전문가에게 귀중한 툴이 되고 있습니다.

의료 현장에서 피브린 실란트의 중요성은 접착력에만 국한되지 않습니다. 피브린 실란트는 출혈을 관리하고 조직 치유를 촉진하는 최소 침습적 솔루션을 제공하여 특정 시술에서 기존 봉합사나 스테이플의 필요성을 줄여줍니다. 또한 피브린 실란트는 항생제나 성장인자 등의 치료제를 상처 부위에 직접 전달하여 치료 효과를 더욱 높일 수 있습니다. 첨단 상처 치료 및 수술 솔루션에 대한 수요가 지속적으로 증가함에 따라 환자 결과와 수술 효율을 향상시키는 피브린 실란트의 역할이 점점 더 많이 인식되고 있습니다.

피브린 실란트의 주요 용도와 헬스케어 요구는 무엇인가?

피브린 실란트는 다양한 의료 분야에서 의료진과 환자의 필요에 따라 폭넓게 활용되고 있습니다. 일반 외과에서 피브린 실란트는 간 절제술, 위 절제술, 대장 절제술과 같은 수술 중 출혈을 조절하기 위해 일반적으로 사용됩니다. 빠른 지혈이 가능하므로 출혈량을 줄이고 합병증 위험을 줄이며 궁극적으로 수술 결과를 개선할 수 있습니다. 또한 피브린 실란트를 이러한 용도로 사용하면 회복 시간을 연장하고 수술 후 통증을 최소화하여 환자와 의료 시설 모두에 도움이 될 수 있습니다.

정형외과수술에서 피브린 실란트는 조직 치유를 지원하고 인공관절 치환술, 인대 수복술, 골절 고정술과 같은 수술 후 합병증 위험을 줄이기 위해 사용됩니다. 피브린 실란트는 조직 접착을 촉진하고 치유 과정을 개선하여 환자의 조기 회복과 기능적 결과를 개선하는 데 기여합니다. 외과 의사들이 수술 결과를 최적화하기 위한 효과적인 솔루션을 찾으면서 근골격계 손상 관리에 대한 적용이 점점 더 보편화되고 있습니다.

뇌신경외과도 피브린 실란트가 인기를 끌고 있는 분야입니다. 이 제품들은 출혈 조절이 중요한 두개골 및 척추 수술 중 출혈 관리에 사용되고 있습니다. 피브린 실란트의 생체 적합성과 접착력은 섬세한 수술 환경에서 사용하기에 이상적이며, 주변 조직을 손상시키지 않고 출혈을 효과적으로 관리할 수 있습니다. 신경외과수술 기술이 발전함에 따라 피브린 실란트의 채택이 증가할 것으로 예상됩니다.

피브린 실란트는 심혈관 수술, 특히 심장 우회술과 판막 치환술에도 사용됩니다. 피브린 실란트는 기존 봉합이 어려운 부위에서 효과적인 지혈을 통해 수술의 정확성을 높이고 수술 후 출혈의 위험을 줄일 수 있습니다. 최소침습적 심혈관 수술에 대한 수요가 증가함에 따라 상처 봉합과 치유를 효과적으로 촉진하는 피브린 실란트와 같은 혁신적인 솔루션에 대한 필요성이 더욱 커지고 있습니다.

또한 피브린 실란트는 상처 치료 및 조직 공학 등 새로운 용도에서도 연구되고 있습니다. 피브린 실란트는 조직 재생을 위한 지원 환경을 제공함으로써 치료가 어려운 상처의 치유를 촉진할 수 있으므로 만성 상처 관리에 대한 적용이 주목받고 있습니다. 연구가 진행됨에 따라 새로운 용도가 발견됨에 따라 헬스케어 산업에서 피브린 실란트의 가능성은 더욱 확대되어 더 광범위한 의료 수요를 충족시킬 수 있을 것입니다.

기술의 발전은 섬유소 실란트 시장에 어떤 영향을 미치고 있는가?

기술의 발전은 제품 제형의 개선, 적용 기술의 향상, 임상 사용의 확대로 인해 피브린 실란트 시장에 큰 영향을 미치고 있습니다. 주목할 만한 개발 중 하나는 피브린 실란트 제제의 기술 혁신으로, 성능과 사용 편의성을 향상시키는 것을 목표로 하고 있습니다. 제조업체들은 점도와 유동성을 최적화한 피브린 실란트를 개발하여 보다 쉽게 도포하고 조직 표면에 더 잘 접착할 수 있도록 하는 데 주력하고 있습니다. 이러한 발전으로 인해 피브린 실란트는 외과 의사들이 더 쉽게 사용할 수 있게 되었으며, 다양한 수술에 적용되고 있습니다.

또한 새로운 전달 시스템의 연구로 인해 피브린 실란트의 잠재적 용도가 확대되고 있습니다. 스프레이 어플리케이터 및 기타 첨단 전달 방법의 개발로 피브린 실란트의 정확하고 정확한 적용이 가능해져 다양한 임상 현장에서의 효능이 향상되고 있습니다. 이러한 전달 혁신으로 의료진은 보다 다양한 시술에 섬유소 실란트를 사용할 수 있게 되어 최적의 성능과 결과를 보장할 수 있게 되었습니다.

피브린 실란트 제제에 생체 적합성 및 생물학적 활성 성분의 통합은 시장에 영향을 미치는 또 다른 추세입니다. 제조업체들은 성장인자, 항균제 및 기타 치료용 첨가제를 피브린 실란트에 통합하여 치유력을 높이기 위해 노력하고 있습니다. 이러한 발전은 조직 재생을 촉진하고 감염 위험을 줄임으로써 환자의 예후를 개선하는 것을 목표로 하고 있습니다. 이러한 기능 강화의 이점이 밝혀지면서 다기능성 피브린 실란트에 대한 수요가 증가할 것으로 예상됩니다.

또한 최소침습 수술 기술의 발전은 피브린 실란트 시장에도 영향을 미치고 있습니다. 외과 의사들이 보다 최소 침습적인 수술법을 채택함에 따라 이러한 수술법을 위한 효과적인 상처 봉합 솔루션에 대한 요구가 증가하고 있습니다. 피브린 실란트는 기존의 봉합사를 사용하지 않고 지혈과 치유를 촉진하기 위한 적절한 옵션을 제공하므로 최소 침습 수술에서 선호되고 있습니다.

피브린 실란트 시장은 환자 안전과 규제 준수에 대한 관심도 혁신의 원동력이 되고 있습니다. 제조업체들은 제품이 최고의 안전성과 유효성 기준을 충족할 수 있도록 연구와 시험에 투자하고 있습니다. 임상적 효과와 안전성이 입증된 피브린 실란트 개발에 집중하는 것은 의료 서비스 프로바이더와 규제 당국의 인정을 받기 위해 필수적입니다. 이러한 품질과 안전성에 대한 노력은 의료계에서 피브린 실란트의 인지도를 높이는 데 도움이 될 것으로 기대됩니다.

피브린 실란트 시장의 성장 원동력은?

피브린 실란트 시장의 성장은 외과수술 증가, 첨단 상처 관리 솔루션에 대한 수요 증가, 수술 후 합병증을 최소화하기 위한 노력 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 주요 요인 중 하나는 전 세계 수술 건수 증가입니다. 헬스케어 산업이 지속적으로 성장함에 따라 효과적인 지혈제 및 상처 봉합 솔루션에 대한 수요가 증가하고 있습니다. 피브린 실란트는 출혈을 억제하고 치유를 촉진할 수 있는 효과적인 옵션을 제공하며, 다양한 외과적 전문 분야에서 필수적인 역할을 하고 있습니다.

첨단 상처 치료 솔루션에 대한 수요 증가도 시장 성장의 중요한 요인입니다. 만성 상처, 욕창, 수술 부위 감염 등이 증가함에 따라 의료 서비스 프로바이더는 상처 치유를 촉진하고 합병증을 줄일 수 있는 혁신적인 접근법을 찾고 있습니다. 조직 회복을 돕고 감염 위험을 줄이는 기능을 가진 피브린 실란트는 상처 관리 분야에서 점점 더 널리 사용되고 있습니다. 환자 안전과 임상 결과 개선에 대한 관심이 높아지면서 효과적인 상처 관리 제품에 대한 수요가 더욱 증가하고 있습니다.

또한 수술 후 합병증을 최소화하고 회복 시간을 연장하는 데 중점을 두고 있는 것도 피브린 실란트 시장에 영향을 미치고 있습니다. 의료 서비스 프로바이더들은 피브린 실란트를 사용하면 출혈을 줄이고 치유를 촉진하며 추가 개입의 필요성을 최소화할 수 있다는 이점을 인식하고 있습니다. 병원과 수술센터가 환자 결과와 효율성을 우선시함에 따라 외과 진료에서 피브린 실란트의 채택이 확대될 것으로 예상됩니다.

또한 수술 기술과 기술의 발전으로 피브린 실란트를 일상적인 수술에 쉽게 통합할 수 있게 되었습니다. 최소 침습 수술이 대중화됨에 따라 이러한 기술에 대응하는 효과적인 상처 봉합 솔루션에 대한 필요성이 점점 더 커지고 있습니다. 피브린 실란트는 기존의 봉합사를 사용하지 않고도 지혈과 치유를 촉진할 수 있는 적절한 옵션을 제공함으로써 다양한 외과적 전문 분야에서 사용이 확대되고 있습니다.

마지막으로 다양한 용도에서 섬유소 실란트의 효능을 조사하는 현재 진행 중인 연구 및 임상 연구가 시장 성장의 원동력이 되고 있습니다. 다양한 수술에서 피브린 실란트의 이점에 대한 새로운 증거가 등장함에 따라 의료 서비스 프로바이더들은 이러한 제품을 진료에 도입할 가능성이 높습니다. 피브린 실란트 사용을 지지하는 임상 데이터가 확대됨에 따라 의료계에서 피브린 실란트의 수용과 사용이 증가할 것으로 보입니다.

결론적으로, 피브린 실란트 시장은 외과수술 증가, 첨단 상처 관리 솔루션에 대한 수요 증가, 수술 후 합병증 최소화에 대한 관심 증가로 인해 크게 성장할 것으로 예상됩니다. 제품 처방 및 전달 방법의 기술 발전은 시장 잠재력을 더욱 높일 것으로 보입니다. 의료 서비스 프로바이더들이 환자의 안전과 효과적인 상처 관리를 최우선 과제로 삼고 있는 가운데, 피브린 실란트에 대한 수요는 향후 수년간 증가할 것으로 예상됩니다.

부문

유형(액체, 패치);&용도(심혈관외과, 정형외과, 일반외과, 이식외과, 기타 용도);&최종 용도(병원, 전문클리닉, 기타 최종 용도)

조사 대상 기업의 예(주목 36사)

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.03.04

Global Fibrin Sealants Market to Reach US$1.6 Billion by 2030

The global market for Fibrin Sealants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Fibrin Sealant Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Fibrin Sealant Patches segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$293.1 Million While China is Forecast to Grow at 9.1% CAGR

The Fibrin Sealants market in the U.S. is estimated at US$293.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$364.1 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Fibrin Sealants Market – Key Trends & Drivers Summarized

What Are Fibrin Sealants, And Why Are They Essential in Medical Applications?

Fibrin sealants are a type of biological adhesive used in various medical applications to promote wound healing and tissue repair. Composed of fibrinogen and thrombin, these sealants mimic the final stages of the blood coagulation process, facilitating the formation of a fibrin clot that effectively seals wounds and enhances hemostasis. Fibrin sealants are used in a wide range of surgical procedures, including general surgery, orthopedics, neurosurgery, and cardiovascular surgery. Their ability to adhere to tissue surfaces, control bleeding, and accelerate healing makes them a valuable tool for surgeons and healthcare professionals.

The significance of fibrin sealants in medical practice extends beyond their adhesive properties. They provide a minimally invasive solution for managing bleeding and promoting tissue healing, reducing the need for traditional sutures and staples in certain procedures. Additionally, fibrin sealants can deliver therapeutic agents, such as antibiotics or growth factors, directly to the wound site, further enhancing their effectiveness. As the demand for advanced wound care and surgical solutions continues to rise, the role of fibrin sealants in improving patient outcomes and surgical efficiency is increasingly recognized.

What Are the Main Applications of Fibrin Sealants, And How Do They Cater to Healthcare Needs?

Fibrin sealants have a wide range of applications across various medical fields, catering to the specific needs of healthcare providers and patients. In general surgery, fibrin sealants are commonly used to control bleeding during procedures such as liver resections, gastric surgeries, and colorectal surgeries. Their ability to provide rapid hemostasis helps reduce blood loss and the risk of complications, ultimately improving surgical outcomes. The use of fibrin sealants in these applications also enhances recovery times and minimizes postoperative pain, benefiting both patients and healthcare facilities.

In orthopedic surgery, fibrin sealants are employed to support tissue healing and reduce the risk of complications following procedures such as joint replacements, ligament repairs, and fracture fixations. By promoting the adhesion of tissues and enhancing the healing process, fibrin sealants contribute to faster recovery and improved functional outcomes for patients. Their application in managing musculoskeletal injuries is becoming increasingly common as surgeons seek effective solutions to optimize surgical results.

Neurosurgery is another area where fibrin sealants are gaining traction. They are used to manage bleeding during cranial and spinal procedures, where controlling hemorrhage is critical. The biocompatibility and adhesive properties of fibrin sealants make them ideal for use in delicate surgical environments, ensuring that bleeding is effectively managed without compromising surrounding tissues. As advancements in neurosurgical techniques continue, the adoption of fibrin sealants is expected to increase.

Fibrin sealants are also used in cardiovascular surgery, particularly in procedures involving cardiac bypass and valve replacement. They provide effective hemostasis in areas where traditional sutures may be challenging to apply, enhancing surgical precision and reducing the risk of postoperative bleeding. The growing demand for minimally invasive cardiovascular procedures is further driving the need for innovative solutions like fibrin sealants that promote effective wound closure and healing.

Furthermore, fibrin sealants are being explored in emerging applications, such as wound care and tissue engineering. Their use in chronic wound management is gaining attention, as they can enhance healing in difficult-to-treat wounds by providing a supportive environment for tissue regeneration. As research continues to uncover new applications, the potential for fibrin sealants in the healthcare industry will likely expand, catering to a broader range of medical needs.

How Are Technological Advancements Impacting the Fibrin Sealants Market?

Technological advancements are significantly influencing the fibrin sealants market by improving product formulations, enhancing application techniques, and expanding their clinical use. One notable development is the innovation in fibrin sealant formulations, which aim to enhance their performance and usability. Manufacturers are focusing on creating fibrin sealants with optimized viscosity and flow characteristics, enabling easier application and improved adhesion to tissue surfaces. These advancements make fibrin sealants more user-friendly for surgeons, contributing to their growing adoption in various surgical procedures.

Additionally, research into novel delivery systems is expanding the potential applications of fibrin sealants. The development of spray applicators and other advanced delivery methods allows for precise and targeted application of fibrin sealants, improving their effectiveness in diverse clinical settings. These delivery innovations enable healthcare providers to use fibrin sealants in a broader range of procedures, ensuring optimal performance and outcomes.

The integration of biocompatible and bioactive components into fibrin sealant formulations is another trend impacting the market. Manufacturers are exploring the incorporation of growth factors, antimicrobial agents, and other therapeutic additives into fibrin sealants to enhance their healing properties. These advancements are aimed at improving patient outcomes by promoting tissue regeneration and reducing the risk of infection. As research continues to uncover the benefits of these enhancements, the demand for multifunctional fibrin sealants is expected to grow.

Moreover, the rise of minimally invasive surgical techniques is influencing the fibrin sealants market. As surgeons increasingly adopt less invasive approaches to procedures, the need for effective wound closure solutions that align with these techniques is rising. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, making them a preferred choice in minimally invasive surgeries.

The emphasis on patient safety and regulatory compliance is also driving innovation in the fibrin sealants market. Manufacturers are investing in research and testing to ensure that their products meet the highest safety and efficacy standards. The focus on developing fibrin sealants with proven clinical benefits and safety profiles is essential for gaining acceptance among healthcare providers and regulatory bodies. This commitment to quality and safety is expected to enhance the reputation of fibrin sealants in the medical community.

What Is Driving the Growth in the Fibrin Sealants Market?

The growth in the fibrin sealants market is driven by several key factors, including increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. One of the primary drivers is the growing number of surgical procedures performed globally. As the healthcare industry continues to expand, the demand for effective hemostatic agents and wound closure solutions is increasing. Fibrin sealants provide an effective option for controlling bleeding and promoting healing, making them essential in various surgical specialties.

The rising demand for advanced wound care solutions is another significant factor contributing to market growth. With an increasing prevalence of chronic wounds, pressure ulcers, and surgical site infections, healthcare providers are seeking innovative approaches to enhance wound healing and reduce complications. Fibrin sealants, with their ability to support tissue repair and reduce infection risks, are becoming increasingly popular in wound management. The ongoing emphasis on patient safety and improved clinical outcomes is further driving the demand for effective wound care products.

Additionally, the focus on minimizing postoperative complications and enhancing recovery times is influencing the fibrin sealants market. Healthcare providers are recognizing the benefits of using fibrin sealants in reducing bleeding, promoting healing, and minimizing the need for additional interventions. As hospitals and surgical centers prioritize patient outcomes and efficiency, the adoption of fibrin sealants in surgical practice is expected to grow.

Moreover, advancements in surgical techniques and technology are facilitating the integration of fibrin sealants into routine surgical practice. As minimally invasive procedures gain popularity, the need for effective wound closure solutions that align with these techniques becomes increasingly important. Fibrin sealants provide a suitable option for achieving hemostasis and promoting healing without the need for traditional sutures, contributing to their growing use in various surgical specialties.

Finally, ongoing research and clinical studies investigating the efficacy of fibrin sealants in different applications are driving market growth. As new evidence emerges regarding the benefits of fibrin sealants in various surgical procedures, healthcare providers are likely to incorporate these products into their practice. The expanding body of clinical data supporting the use of fibrin sealants will enhance their acceptance and utilization in the medical community.

In conclusion, the fibrin sealants market is poised for significant growth driven by increasing surgical procedures, rising demand for advanced wound care solutions, and a focus on minimizing postoperative complications. Technological advancements in product formulations and delivery methods will further enhance the market's potential. As healthcare providers continue to prioritize patient safety and effective wound management, the demand for fibrin sealants is expected to flourish in the coming years.

SCOPE OF STUDY:

The report analyzes the Fibrin Sealants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Liquid, Patches); Application (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery, Other Applications); End-Use (Hospitals, Specialty Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Adhesys Medical GmbH
  • Baxter
  • Covidien Inc.
  • CSL Behring
  • Ethicon
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Stryker
  • Takeda Pharmaceutical
  • Vivostat A/S

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Fibrin Sealants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Adoption of Fibrin Sealants in Hemostasis and Wound Healing Expands Addressable Market
    • Surge in Demand for Fibrin Sealants in Minimally Invasive Surgeries Fuels Market Growth
    • Growing Focus on Fibrin Sealants for Reducing Blood Loss and Postoperative Complications Strengthens Business Case
    • Surge in Adoption of Fibrin Sealants in Orthopedic and Trauma Surgeries Expands Market Opportunities
    • Growing Demand for Fibrin Sealants in Dental and Maxillofacial Surgeries Expands Addressable Market
    • Surge in Adoption of Fibrin Sealants in Plastic and Reconstructive Surgeries Expands Market Opportunities
    • Technological Advancements in Fibrin Sealants for Enhanced Biocompatibility Propel Market Growth
    • Growing Use of Fibrin Sealants in Neurosurgery and Spinal Procedures Strengthens Business Case
    • Rising Adoption of Fibrin Sealants in Emerging Markets with Expanding Healthcare Infrastructure Sets the Stage for Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fibrin Sealants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Liquid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Liquid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Patches by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Patches by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cardiovascular Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Cardiovascular Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Transplant Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Transplant Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Fibrin Sealants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fibrin Sealants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fibrin Sealants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fibrin Sealants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fibrin Sealants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fibrin Sealants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fibrin Sealants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Type - Liquid and Patches - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fibrin Sealants by Type - Liquid and Patches Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fibrin Sealants by Type - Percentage Breakdown of Value Sales for Liquid and Patches for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fibrin Sealants by End-Use - Other End-Uses, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fibrin Sealants by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals and Specialty Clinics for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Fibrin Sealants by Application - Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Fibrin Sealants by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Transplant Surgery and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제